🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

Recruitingn/aAges 18 Years - anyAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06833632 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * obtaining voluntary written informed consent * diagnosis of NSCLC * clinical stage I-IIA cN0 * Candidates for surgical resection Exclusion Criteria: * Pregnancy * Induction therapy for pulmonary neoplasia * Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery * Any previous surgery for lung cancer * Patients with other active neoplasms * Infiltration of the chest wall
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS - Azienda Ospedaliero Universitaria di Bologna
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy